The maker of Viagra, Lipitor and Advil has been slashing thousands of jobs since acquiring rival Wyeth in 2009.
Now, as several of its key products run out of patent protection, it is also downsizing its research and development spending.
The company plans to still cut another 5,530 employees -- or 5% of its global workforce. While many of those jobs cuts will come from the closure of a factory in Sandwich, England, they will also affect many U.S. employees who work in R&D roles.
These young job seekers graduated into the worst labor market since the Great Depression.
|Anger over the end of 'The Interview'|
|Google is the Big Tech stock loser of 2014|
|10 things you need to know about Russia|
|U.S. is set to blame North Korea for the Sony hack|
|Activists plan to drop 'Interview' DVDs in North Korea|